Healthcare Equipment and Supplies
Company Overview of Miramar Labs, Inc.
Miramar Labs, Inc. develops medical devices. The company focuses on developing products for dermatologic medical conditions. Its products include miraDry System for the treatment of primary auxiliary (underarm) hyperhidrosis in adults; and miraWave technology, a technology platform using microwave energy for treatment in dermatologic conditions and other medical areas, such as oncology, cardiology, and urology. The company was formerly known as Foundry Newco X, Inc. Miramar Labs, Inc. was founded in 2006 and is based in Santa Clara, California.
2790 Walsh Avenue
Santa Clara, CA 95051
Founded in 2006
Key Executives for Miramar Labs, Inc.
Chief Executive Officer, President and Director
Co-Founder and Chairman of the Board
Chief Financial Officer and Senior Vice President
Vice President of Law and General Counsel
Managing Director for Asia Pacific
Compensation as of Fiscal Year 2014.
Miramar Labs, Inc. Key Developments
Miramar Labs, Inc. Announces Management Changes
Feb 10 14
Miramar Labs, Inc. announced the appointment of R. Michael Kleine as its new president, chief executive officer and a member of its board of directors. Mr. Kleine will succeed Darrell Zoromski, the company's current president and CEO, who had previously announced his intent to step down in order to spend more time with his family. Prior to joining Miramar Labs, Mr. Kleine was most recently the CEO of EndoGastric Solutions (EGS) and will continue to serve as its Chairman of the Board. Mr. Zoromski played an active role in the CEO search and will continue to support the company in the coming months to ensure a smooth leadership transition.
Miramar Labs Announces CE Mark Approval for the miraDry(R) System to Treat Bothersome Underarm Sweat
Jan 6 14
Miramar Labs(R) Inc. announced that the miraDry(R) System received Conformite Europeenne (CE) Mark approval for the treatment of primary axillary hyperhidrosis, commonly known as bothersome underarm sweat. Clearance for miraDry was granted by the U.S. Food and Drug Administration in January 2011 following a robust, randomized, blinded clinical study that involved 120 patients at seven clinics followed for 12 months post-treatment. A follow up study was conducted in Canada that showed patients experienced sustained improvement in sweat reduction and quality of life 24-months post treatment.
Miramar Labs Inc., Wins $1,500,000.00 Federal Contract
Nov 16 13
Miramar Labs Inc. announced that it has won a VA National Acquisition Center (Department of Veterans Affairs), Department of Veterans Affairs National Acquisition Center, has awarded a $1,500,000.00 modified federal contract on Nov. 15 for '65--Miramar Labs, Inc. 65IIA Medical Equipment & Supplies - V797D-40031 November 15, 2013 to November 14, 2018.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|